Verde Science, Inc. Announces Appointment of Mr. Ken Berscht as Chief Executive Officer
16 Junho 2014 - 10:00AM
Marketwired
Verde Science, Inc. Announces Appointment of Mr. Ken Berscht as
Chief Executive Officer
Capital Markets Veteran to Implement Company's Plan to Become
Strategic Leader in the Burgeoning Medical Marijuana Industry
LOS ANGELES, CA--(Marketwired - Jun 16, 2014) - Verde Science,
Inc. (OTCBB: VRCI) Board of Directors of is pleased to announce the
appointment of Mr. Ken Berscht to the position of CEO. The Board of
Directors welcomes Ken with great enthusiasm and believe they have
found a dynamic and engaging leader to guide Verde through the maze
of regulatory and financial hurdles in this nascent business
opportunity. Mr. Berscht stated, "I am honored by the opportunity
to lead Verde Science as the medical marijuana space is undergoing
such a fundamental transfiguration."
Mr. Harp Sangha the outgoing CEO and creator of Verde's current
vision shared, "Since the inception of Verde's current path towards
being a dominant force in the North American horticultural and
marijuana industry, I have been building a team of experienced
management from the medical marijuana industry and public company
sector management. Ken is the next cog in that wheel to
complete the current team. I am can now step down as CEO with
confidence and assume a less day to day role in the company as a
member of the board of directors."
Mr. Ken Berscht is a graduate of the University of Western
Ontario Business School where he received an honors degree in
Business with a major in advertising and marketing. Earlier in his
career he was qualified as an International Financial Advisor in
England, and a member of the Society of Mining, Metallurgy and
Exploration.
He has been a member of the Investment Dealers Association in
Canada and as a principle member with NASDAQ and the NYSE in the
USA.
During his career he has been a senior investment advisor with
Yorkton Securities and Canaccord Capital. He has extensive
experience in all aspects of the financial community with clients
from Europe and Asia in addition to an extensive North American
network.
In Taiwan Mr. Berscht had a ground breaking business and
attracted over 3,000 clients to the North American market making
him one of the largest brokers in Canada at the time.
Mr. Berscht was the vice president of Enerplus International, a
division of one of Canada's largest income trusts. He spent
considerable time in Europe and the Cayman Islands. In the Caymans,
he also managed an oil and gas fund for 10 years and is qualified
there as a mutual fund administrator.
Throughout his career Mr. Berscht has always been on the leading
edge of industry trends. He was one of the pioneers launching the
JCP and CPC financing. He has always been a pioneer the market,
trailblazing new opportunities as they present themselves.
About Verde Science Verde Science plans to take an
all-encompassing, integrated public health approach to medical
marijuana with a focus on becoming the leader in providing services
to legal, licensed cannabis cultivators and dispensaries and their
patient community. Verde's focus, in collaboration with its
partners, is on deploying an advanced array of technical services
to foster an integrated health care model in legal jurisdictions in
North America.
The Company provides a variety of products and services to its
clients by using best practices to ensure the best quality of
product, produced with focus on cost control and legal compliance.
Verde Science is meticulous, measured and diligent with an absolute
focus on compliance while offering growers and their patient
community unsurpassed, fully integrated, holistic health care
products and programs.
http://verdescienceinc.com is one of the initial corporate
players in the medical marijuana industry providing sophistication,
controls, standards and innovation. The company has and will
continue to assemble a highly experienced team that will deploy
state-of-the-art technology and a superior methodology to enter and
take meaningful market share that can be repeated and expanded as
more and more jurisdictions adopt legal use of cannabis products to
address health care issues.
Safe Harbor Statements Certain information contained in this
news release constitutes "forward-looking statements" as such term
is used in applicable United States and Canadian laws. Generally,
these forward-looking statements can be identified by the use of
forward-looking terminology such as "expects" or "does not expect",
"is expected", "anticipates" or "does not anticipate", "plans",
"estimates", "intends" or "believes", or that certain actions,
events or results "may", "could", "would", "might" or "will be
taken", "occur", or "be achieved". Forward-looking statements
are based on the opinions and estimates of management as of the
date such statements are made, and are subject to known and unknown
risks, uncertainties and other factors that may cause the actual
results, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements. Many of these factors are beyond the
Company's ability to control or predict. Important factors that may
cause actual results to differ materially and that could impact the
Company and the statements contained in this news release can be
found in the Company's filings with the SEC. Such risks and other
factors include, among others, the ability to locate and acquire
suitable interests in alternative medicine manufacturing operations
on terms acceptable to the Company, the availability of financing
on acceptable terms, accidents, labor disputes, acts of God and
other risks of the alternative medicine industry including, without
limitation, delays in obtaining governmental approvals or permits,
title disputes or claims limitations on insurance coverage. The
Company believes that the expectations reflected in the
forward-looking statements included in this news release are
reasonable; however, no assurance can be given that these
expectations will prove to be correct, and such forward-looking
statements should not be unduly relied upon. The Company assumes no
obligation to update or supplement any forward-looking statements
whether as a result of new information, future events or
otherwise.
For further information please contact: Harp Sangha
Chairman/Director 1-858-210-0236
harpsangha@shaw.ca Torrey Hills Capital Jim MacDonald/Clay Chase
1-858-759-9902
Verde Science (CE) (USOTC:VRCI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Verde Science (CE) (USOTC:VRCI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024